• Facebook
  • Rss
  • Twitter
  • Youtube
  • Store
  • Donate
NCCS - National Coalition for Cancer Survivorship
  • About
    • Our Mission
    • Our History
    • Our Leadership
      • Policy Advisors
    • Employment
    • Partnerships
    • Financial Information
  • Policy
    • Quality Cancer Care
    • Access to Care
    • Health Equity
    • Redefining Functional Status (RFS)
    • 2020 State of Cancer Survivorship Survey
    • Cancer Care Planning and Communications Act (CCPCA)
  • Get Involved
    • What is Advocacy?
    • Cancer Policy and Advocacy Team (CPAT)
    • Elevating Survivorship
    • Survivor Stories
    • Cancerversary
    • State Based Cancer Advocacy
  • Resources
    • COVID-19 Resources for Cancer Survivors
    • Survivorship Checklist
    • Cancer Survival Toolbox
    • Telehealth
    • Publications
      • Talking With Your Doctor
      • Self Advocacy
      • Employment Rights
      • Remaining Hopeful
    • Cancer Convos Podcast
    • Taking Charge of Your Care
    • Care Planning for Cancer Survivors
    • Tools For Care Providers
    • Order Our Resources
  • News
  • Events
    • From Shadows to Life: A Biography of the Cancer Survivorship Movement
    • Ellen L. Stovall Award
      • 2020 Stovall Awards
      • Honorees
      • Sponsors
      • Committees
      • Reception
      • Nominations
    • Cancer Policy Roundtable
      • Fall 2020 Cancer Policy Roundtable
      • Spring 2020 Cancer Policy Roundtable
    • Cancer Policy and Advocacy Team (CPAT) Symposium 2020
    • Webinars
  • Contact Us
  • Search
  • Menu Menu
  • 0Shopping Cart

Year-End MATCH (DEADLINE Dec 31): Donate & Make a Difference | Donate

affordable care act

NCCS Position Statement on Actions to Undermine ACA

October 13, 2017/in Cancer News, Cancer Policy Blog, NCCS News Access to Care, Affordable Care Act, Financial Toxicity, Health Care Coverage, Health Equity, Pre-Existing Conditions NCCS News /by actualize


October 13, 2017

The National Coalition for Cancer Survivorship (NCCS) is alarmed by the actions President Trump took this week to undermine the Affordable Care Act. These decisions are likely to destabilize the individual insurance market and put affordable and adequate health insurance out of reach for millions of Americans. The health and well-being of cancer patients and millions of additional Americans are under threat as a result of these actions, as many will be unable to afford insurance coverage. Those at greatest risk for limited access to affordable coverage are those with pre-existing conditions.

These actions, and their potential effects on cancer patients, include:

  • Directing federal departments to revise rules and regulations to encourage the marketing and purchase of association health plans and short-term limited duration insurance. These efforts will harm cancer patients – and all Americans except those who are healthy today – by separating the healthy and the sick into risk pools, thereby collapsing the individual market. These efforts will also result in the marketing and purchase of bare bones “junk” insurance policies that are inadequate for any Americans with health issues. Those who purchase these junk plans today while healthy will be left with wholly inadequate insurance if they are diagnosed with cancer.
  • Refusing to fund the cost-sharing reductions that ensure that low-income Americans have assistance with deductibles and cost-sharing. This decision will immediately cause increases in premiums in the individual market, but the subsequent effects will likely be the withdrawal of insurers from the marketplace and potentially the collapse of insurance markets. Many consumers will be unable to obtain insurance coverage at all and many more will be unable to find affordable coverage. These $7 billion in annual subsidies to health insurers allow around 7 million low-income Americans to afford coverage. The Congressional Budget Office says that ending CSR payments will result in 1 million more Americans uninsured, premiums will rise by 20% and the deficit would rise by $194 billion. As the Washington Post reports, the uncertainty about what Trump would do has already driven premium prices higher for 2018.

NCCS will intensify its efforts in opposition to proposals that will bifurcate the pool of Americans in the individual market, as we think these efforts do not achieve the goals of providing Americans more affordable insurance and a wider range of insurance options. Instead, these efforts threaten the individual insurance market. We also call on Congress to act immediately to ensure the funding of cost-sharing reductions. This is a modest but absolutely critical step for stabilizing the insurance markets.

# # #

Read more of our coverage on the attempts to repeal the Affordable Care Act »


Tags: Advocacy, affordable care act, Cancer Survivorship, exchange plans, financial issues, position statment, pre-existing conditions, short-term health plans
Share this entry
  • Share on Facebook
  • Share on Twitter
https://canceradvocacy.org/wp-content/uploads/2017/10/white-house.jpg 686 1030 actualize https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png actualize2017-10-13 17:12:532017-10-13 17:12:53NCCS Position Statement on Actions to Undermine ACA
You might also like
Fotolia 23428619 S e1461260836640 Second Anniversary of State Exchanges: Affordable Options for Cancer Patients, But the Devil Remains in the Details
FacebookProfile3 The National Coalition for Cancer Survivorship Applauds Healthcare Reform
ProtectOurCare 1024px ACA Update | How the Newly-Signed Tax Bill Affects Patients, and a Thank You to Patient Advocates Across the U.S.
NCCS Starburst 250px Health Care Roundup: ACA Erased Key Racial Cancer Disparity; ‘Survivor’ Debate; Isolation in Survivorship; Remembering Two Cancer Pioneers; More
ProtectOurCare 1024px ACA Update | October 13, 2017 – Trump Administration Cuts Off Cost-Sharing Payments, Signs Executive Order to Undermine the ACA
NCCS Blog CPM Logo NCCS Concerned About New CMS Guidance on 1332 Waiver Process
20years Guest Post by Dr. Patricia Ganz: What Cancer Patients and Their Families Can Do to Coordinate Post-Treatment Care
Fotolia 23428619 S e1461260836640 NCCS Statement on CBO Report of Revised American Health Care Act

Latest News

Coronavirus feat

COVID-19 Vaccines and Cancer: A Conversation with Cancer Expert Otis Brawley, MD

March 1, 2021
The National Coalition for Cancer Survivorship (NCCS) hosted a conversation on February…
Read more
https://canceradvocacy.org/wp-content/uploads/2020/03/Coronavirus-feat.jpg 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2021-03-01 11:49:192021-03-02 16:15:47COVID-19 Vaccines and Cancer: A Conversation with Cancer Expert Otis Brawley, MD
Canceradvocacy org default image

National Quality Forum Names NCCS CEO Shelley Fuld Nasso to 2021 Leadership Consortium Roster

February 24, 2021
NOTE: This press release was originally published on the National Quality Forum (NQF)…
Read more
https://canceradvocacy.org/wp-content/uploads/2019/10/Canceradvocacy-org-default-image.jpg 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2021-02-24 21:01:392021-02-24 21:01:39National Quality Forum Names NCCS CEO Shelley Fuld Nasso to 2021 Leadership Consortium Roster
HHS Humphrey bldg 1200

NCCS and Other Cancer Groups Urge HHS to Keep Six Protected Classes in Medicare Part D Drug Plans

February 19, 2021
The National Coalition for Cancer Survivorship (NCCS) joined with the Cancer Leadership…
Read more
https://canceradvocacy.org/wp-content/uploads/2017/10/HHS-Humphrey-bldg-1200.jpg 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2021-02-19 15:06:392021-02-24 19:29:10NCCS and Other Cancer Groups Urge HHS to Keep Six Protected Classes in Medicare Part D Drug Plans

Take Action

Stovall Award

The Ellen L. Stovall Award for Innovation in Patient-Centered Cancer Care is a unique opportunity for patients and survivors to recognize pioneers who are transforming the cancer care system.

Join CPAT

The NCCS Cancer Policy & Advocacy Team (CPAT) is a program for survivors and caregivers to learn about pressing policy issues that affect quality cancer care in order to be engaged as advocates in public policy around the needs of cancer survivors.

Share Your Story

NCCS represents the millions of Americans who share a common experience – the survivorship experience – living with, through and beyond a cancer diagnosis.

STAY CONNECTED

Together we can improve cancer care for survivors! Sign up to be the first to know about cancer policy issues and ways to take action

  • About
    • Our Mission
    • Our History
    • Our Leadership
      • Policy Advisors
    • Employment
    • Partnerships
    • Financial Information
  • Policy
    • Quality Cancer Care
    • Access to Care
    • Health Equity
    • Redefining Functional Status (RFS)
    • 2020 State of Cancer Survivorship Survey
    • Cancer Care Planning and Communications Act (CCPCA)
  • Get Involved
    • What is Advocacy?
    • Cancer Policy and Advocacy Team (CPAT)
    • Elevating Survivorship
    • Survivor Stories
    • Cancerversary
    • State Based Cancer Advocacy
  • Resources
    • COVID-19 Resources for Cancer Survivors
    • Survivorship Checklist
    • Cancer Survival Toolbox
    • Telehealth
    • Publications
      • Talking With Your Doctor
      • Self Advocacy
      • Employment Rights
      • Remaining Hopeful
    • Cancer Convos Podcast
    • Taking Charge of Your Care
    • Care Planning for Cancer Survivors
    • Tools For Care Providers
    • Order Our Resources
  • News
  • Events
    • From Shadows to Life: A Biography of the Cancer Survivorship Movement
    • Ellen L. Stovall Award
      • 2020 Stovall Awards
      • Honorees
      • Sponsors
      • Committees
      • Reception
      • Nominations
    • Cancer Policy Roundtable
      • Fall 2020 Cancer Policy Roundtable
      • Spring 2020 Cancer Policy Roundtable
    • Cancer Policy and Advocacy Team (CPAT) Symposium 2020
    • Webinars
  • Contact Us

National Coalition for Cancer Survivorship
8455 Colesville Road  |  Suite 930  |  Silver Spring, MD 20910
877-NCCS-YES  |  info@canceradvocacy.org
Privacy Policy  |  Terms and Conditions

Copyright © 1995-2021 by the National Coalition for Cancer Survivorship
National Coalition for Cancer Survivorship, NCCS, Cancer Survival Toolbox, and related Logos are registered in the United States as trademarks of the National Coalition for Cancer Survivorship.

What Caught Our Eye: Trump Acts to Undermine ACA; Susan Gubar Reviews ‘Cancer... NCCS Starburst 250px ProtectOurCare 1024px ACA Update | October 13, 2017 – Trump Administration Cuts Off Cost-Sharing...
Scroll to top

Harmar Brereton, MD

Founder
Northeast Regional Cancer Institute

 

“Perhaps one of the most impactful collaborations in Dr. Brereton’s extraordinary career remains his early work and long friendship with Ellen Stovall. Through him, and in turn through the thousands of lives he has touched, Ellen’s work continues, and her mission lives on.”

—Karen M. Saunders
President, Northeast Regional Cancer Institute